Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Reggiori

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Radiation Oncology (London, England)|April 29, 2017
RapidPlan head and neck model: the objectives and possible clinical benefitA Fogliata, G Reggiori, A Stravato, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2012
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicityF Alongi, A Fogliata, P Navarria, et al.
Minerva Chirurgica|March 31, 1988
[Territorial mass screening for colorectal tumors]S Dall'Acqua, G Tessera, A De Bernardi, et al.
Chirurgia E Patologia Sperimentale|April 1, 1979
[Acute experimental hepatic insufficiency caused by total ischemia of the liver: effect of peritoneal dialysis]I Cassina, G Reggiori, G L Tagliatesta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2021
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boostD Franceschini, A Fogliata, R Spoto, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 9, 2016
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 PatientsG D'Agostino, C Franzese, F De Rose, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic RadiotherapyC Franzese, P Navarria, L Bellu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2023
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient SurvivalC Franzese, R Lucchini, M Roghi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2011
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patientsF Alongi, M Bignardi, I Garassino, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Radiation Oncology (London, England)|April 29, 2017
RapidPlan head and neck model: the objectives and possible clinical benefitA Fogliata, G Reggiori, A Stravato, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2012
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Report of feasibility and acute toxicityF Alongi, A Fogliata, P Navarria, et al.
Minerva Chirurgica|March 31, 1988
[Territorial mass screening for colorectal tumors]S Dall'Acqua, G Tessera, A De Bernardi, et al.
Chirurgia E Patologia Sperimentale|April 1, 1979
[Acute experimental hepatic insufficiency caused by total ischemia of the liver: effect of peritoneal dialysis]I Cassina, G Reggiori, G L Tagliatesta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2021
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boostD Franceschini, A Fogliata, R Spoto, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 9, 2016
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 PatientsG D'Agostino, C Franzese, F De Rose, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 14, 2022
Risk-group Classification by Recursive Partitioning Analysis of Patients Affected by Oligometastatic Renal Cancer Treated with Stereotactic RadiotherapyC Franzese, P Navarria, L Bellu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2023
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient SurvivalC Franzese, R Lucchini, M Roghi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2011
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patientsF Alongi, M Bignardi, I Garassino, et al.
Pageof 2